These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9892859)

  • 1. Effects of fluoxetine and dothiepin on 24-hour activity in depressed patients.
    Stanley N; Fairweather DB; Hindmarch I
    Neuropsychobiology; 1999; 39(1):44-8. PubMed ID: 9892859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised, double-blind, parallel-group comparison of venlafaxine and dothiepin in geriatric patients with major depression.
    Mahapatra SN; Hackett D
    Int J Clin Pract; 1997 Jun; 51(4):209-13. PubMed ID: 9287259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind multi-centre trial of fluoxetine and dothiepin in major depressive illness. South Wales Antidepressant Drug Trial Group.
    Int Clin Psychopharmacol; 1988 Jan; 3(1):75-81. PubMed ID: 3282004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance with antidepressant medication in the treatment of major depressive disorder in primary care: a randomized comparison of fluoxetine and a tricyclic antidepressant.
    Thompson C; Peveler RC; Stephenson D; McKendrick J
    Am J Psychiatry; 2000 Mar; 157(3):338-43. PubMed ID: 10698807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and acceptability of amineptine versus fluoxetine in major depression.
    Dalery J; Rochat C; Peyron E; Bernard G
    Int Clin Psychopharmacol; 1997 Jul; 12 Suppl 3():S35-8. PubMed ID: 9347391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, randomized, 26-week study comparing the cognitive and psychomotor effects and efficacy of 75 mg (37.5 mg b.i.d.) venlafaxine and 75 mg (25 mg mane, 50 mg nocte) dothiepin in elderly patients with moderate major depression being treated in general practice.
    Trick L; Stanley N; Rigney U; Hindmarch I
    J Psychopharmacol; 2004 Jun; 18(2):205-14. PubMed ID: 15260909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.
    Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF
    Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, comparative study of dothiepin and clomipramine in the treatment of major depressive illness.
    Welch CP; Tweed JA; Smithers A; Gostick NK; Raniwalla J
    Int J Clin Pract; 1997 Sep; 51(6):360-3. PubMed ID: 9489063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparative study of fluoxetine and dothiepin in the treatment of depression in general practice.
    Corne SJ; Hall JR
    Int Clin Psychopharmacol; 1989 Jul; 4(3):245-54. PubMed ID: 2677126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind study of the efficacy and safety of dothiepin hydrochloride in the treatment of major depressive disorder.
    Stratas NE
    J Clin Psychiatry; 1984 Nov; 45(11):466-9. PubMed ID: 6386793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of trimipramine and fluoxetine on sleep in geriatric depression.
    Wolf R; Dykierek P; Gattaz WF; Maras A; Kohnen R; Dittmann RW; Geuppert M; Riemann D; Berger M
    Pharmacopsychiatry; 2001 Mar; 34(2):60-5. PubMed ID: 11302565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine (prozac) in depresion of adults.
    Kocur J; Rydzynski Z; Duszyk S; Gruszczynski W; Trendak W
    Homeost Health Dis; 1991; 33(5-6):295. PubMed ID: 18265505
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescribing of venlafaxine and dosulepin in primary care.
    McAllister-Williams RH; Foran K; Forrest S; Ingram G; McMahon L; Taylor M; Rajwal MS; Cornwall PL
    J Psychopharmacol; 2006 Nov; 20(6):868. PubMed ID: 17060347
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients.
    Wehmeier PM; Kluge M; Maras A; Riemann D; Berger M; Kohnen R; Dittmann RW; Gattaz WF
    Pharmacopsychiatry; 2005 Jan; 38(1):13-6. PubMed ID: 15706460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dothiepin versus doxepin in major depression: results of a multicenter, placebo-controlled trial. Prothiaden Collaborative Study Group.
    Ferguson JM; Mendels J; Manowitz NR
    J Clin Psychiatry; 1994 Jun; 55(6):258-63. PubMed ID: 8071282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.
    Marchesi C; Ceccherininelli A; Rossi A; Maggini C
    Pharmacopsychiatry; 1998 Nov; 31(6):216-21. PubMed ID: 9930635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Course of psychomotor agitation during pharmacotherapy of depression: analysis from double-blind controlled trials with fluoxetine.
    Tollefson GD; Sayler ME
    Depress Anxiety; 1996-1997; 4(6):294-311. PubMed ID: 9166658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 20. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
    Joyce PR; Mulder RT; McKenzie JM; Luty SE; Cloninger CR
    Depress Anxiety; 2004; 19(3):180-6. PubMed ID: 15129420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.